ALLR
Allarity Therapeutics Inc
NASDAQ: ALLR · HEALTHCARE · BIOTECHNOLOGY
$1.35
-2.17% today
Updated 2026-04-30
Market cap
$21.83M
P/E ratio
—
P/S ratio
68.22x
EPS (TTM)
$-0.78
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
Allarity Therapeutics Inc (ALLR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | — | $-2.03M | $-3.98M | $-1.34M | $-4.24M | $-10.11M | $-7.25M | $-15.05M | $-16.82M | $-12.74M | $-17.35M | $-14.82M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $77842.00 | $37000.00 | $5677.00 | $8000.00 | $3000.00 | $18000.00 | $18000.00 | $0.00 | $298000.00 | $8000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | $2.33M | $214055.00 | $333000.00 | $616000.00 | $6.37M | $1.75M | $-71000.00 | $71000.00 | $482000.00 |
| Free cash flow | — | — | $-2.03M | $-4.06M | $-1.38M | $-4.24M | $-10.12M | $-7.25M | $-15.07M | $-16.84M | $-12.74M | $-17.65M | $-14.83M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | $1.51M | $10.99M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | $-17.34M | — | — | — |